Stock listing

Kura Oncology, Inc.

Selected listing: KUR · GETTEX · EUR · DE

Kura Oncology, Inc. (gettex:KUR), Health Technology. Latest release Oct 2, 2026: Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

KUR:GETTEXEURDEUpdated October 2, 2026

Ticker: gettex:KUR
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: gettex
Currency: EUR

Latest news from Kura Oncology, Inc.

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 1, 2026

A Taste of Mystery: Kura Sushi USA and Crunchyroll Brew Up a New Collab with The Apothecary Diaries

September 17, 2026

Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes

September 9, 2026

Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer

September 8, 2026

Kura Oncology to Participate in Three Investor Conferences in September

September 1, 2026

All Kura Oncology, Inc. news →

Events

Replays

Kura Oncology, Inc. (KURA) Q2 2026 Earnings Call
Wed, Aug 12, 2026 · 04:30 PM ET
Watch
Kura Oncology, Inc. (KURA) Q1 2026 Earnings Call
Tue, May 12, 2026 · 04:30 PM ET
Watch
Kura Oncology, Inc. (KURA) Q4 2025 Earnings Call
Thu, Mar 05, 2026 · 08:00 AM ET
Watch

Research Kura Oncology, Inc.

Kura Oncology, Inc. company profile

View the public company page for Kura Oncology, Inc. on 6ix.

Kura Oncology, Inc. news

Read company news and market updates connected to Kura Oncology, Inc..

Kura Oncology, Inc. investor events

Find investor webinars, events, and replay context for Kura Oncology, Inc..